|
시장보고서
상품코드
2050938
약물감시 시장 : 임상시험 단계별, 방법별, 서비스 제공업체별, 지역별Pharmacovigilance Market, By Clinical Trial Phases, By Type of Method, By Type of Service Provider, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
약물감시 시장은 2026년에 87억 1,000만 달러로 추정되며, 2033년까지 154억 2,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 8.5%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 87억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.50% | 2033년 시장 규모 예측 : | 154억 2,000만 달러 |
세계 약물감시 시장은 최근 몇 년 동안 괄목할 만한 성장세를 보이고 있습니다. 약물감시란 부작용 및 기타 의약품 관련 문제를 감지, 평가, 이해 및 예방하는 과학 및 활동을 말합니다. 의약품 분자가 복잡해지고 새로운 치료법이 시장에 출시됨에 따라 시판 후 의약품의 안전성을 효과적으로 모니터링할 필요성이 높아지고 있습니다. 의약품 안전성 모니터링을 의무화하는 엄격한 규제 프레임워크와 더불어 약물 부작용 발생 건수 증가는 전 세계적으로 약물감시 서비스에 대한 수요를 증가시키고 있습니다. 또한, 제네릭 의약품 시장의 확대와 신흥 지역으로의 임상시험 아웃소싱도 약물감시 시장의 성장을 가속하고 있습니다.
시장 역학
세계 약물감시 시장은 의약품 부작용 증가, 의약품 승인에 대한 엄격한 안전 규제, 효과적인 치료법에 대한 수요 증가, 제네릭 의약품 시장 확대에 힘입어 성장하고 있습니다. 시판 후 조사를 의무화하는 엄격한 규제 가이드라인은 약물감시 서비스 수요를 확대하는 중요한 요인으로 작용하고 있습니다. 또한, 안전성 문제로 인한 의약품 리콜 증가 추세로 인해 제약사들은 약물감시 업무를 전문 서비스 제공업체에 위탁할 수 밖에 없는 상황입니다. 또한, 선진국의 제네릭 의약품 시장 확대는 약물감시 시장 기업들에게 큰 기회를 제공합니다. 그러나 중소 제약사의 예산 제약과 지역 간 의약품 안전성 데이터 보고의 복잡성은 시장 참여자들에게 도전이 되고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 약물감시 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 약물감시 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 약물감시 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 약물감시 시장 : 임상시험 단계별, 2021년-2033년
제5장 세계의 약물감시 시장 : 방법별, 2021년-2033년
제6장 세계의 약물감시 시장 : 서비스 제공업체 유형별, 2021년-2033년
제7장 세계의 약물감시 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
LSH 26.06.15Pharmacovigilance Market is estimated to be valued at USD 8.71 Bn in 2026 and is expected to reach USD 15.42 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.71 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.50% | 2033 Value Projection: | USD 15.42 Bn |
The global pharmacovigilance market has been witnessing significant growth in the recent years. Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, prevention of adverse effects or any other drug-related problems. With the growing complexity of drug molecules and the introduction of novel therapies in the market, there is an increasing need to effectively monitor the safety of drugs post marketing. Stringent regulatory framework mandating drug safety monitoring along with increasing instances of adverse drug reactions is propelling the demand for pharmacovigilance services across the globe. Furthermore, the expanding generics market and outsourcing of clinical trials to emerging regions has further boosted the pharmacovigilance market.
Market Dynamics
The global pharmacovigilance market is driven by the rising number of adverse drug reactions, stringent safety regulations for drug approval, increasing demand for efficacious therapies, and growing generics market. Stringent regulatory guidelines mandating post marketing surveillance is a key factor augmenting the demand for pharmacovigilance services. Furthermore, rising trend of drug recalls due to safety issues has compelled pharmaceutical companies to outsource their pharmacovigilance activities to specialized service providers. Moreover, increasing generics market in developed countries offer significant opportunities for the pharmacovigilance market players. However, budget constraints of small and midsize pharmaceutical companies and complexity of reporting drug safety data across regions pose challenges to market players.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pharmacovigilance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Accenture, Cognizant Technology Solutions, Laboratory Corporation of America Holdings (LabCorp), IBM Corporation, QuintilesIMS (IQVIA), ICON plc, Capgemini, ITClinical, TAKE Solutions Ltd, BioClinica, PAREXEL International Corporation, Wipro Ltd, FMD K&L, Linical Accelovance, United BioSource Corporation (UBC), PRA Health Sciences, ArisGlobal, and Ennov Solutions Inc
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacovigilance market
Market Segmentation
- Clinical Trial Phases Insights (Revenue, USD Bn, 2026 - 2033)
- Pre-clinical Studies
- Clinical Trial Phase I
- Clinical Trial Phase II
- Clinical Trial Phase III
- Post Marketing Surveillance or Phase IV
- Method Insights (Revenue, USD Bn, 2026 - 2033)
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Reporting
- Cohort Event Monitoring
- EHR Monitoring
- Service Provider Insights (Revenue, USD Bn, 2026 - 2033)
- In-House
- Contract Outsourcing
- Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Accenture
- Cognizant Technology Solutions
- Laboratory Corporation of America Holdings (LabCorp)
- IBM Corporation
- QuintilesIMS (IQVIA)
- ICON plc
- Capgemini
- ITClinical
- TAKE Solutions Ltd
- BioClinica
- PAREXEL International Corporation
- Wipro Ltd
- FMD K&L
- Linical Accelovance
- United BioSource Corporation (UBC)
- PRA Health Sciences
- ArisGlobal
- Ennov Solutions Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Clinical Trial Phases
- Market Snapshot, By Type of Method
- Market Snapshot, By Type of Service Provider
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Pharmacovigilance Market, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pre-clinical Studies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clinical Trial Phase I
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clinical Trial Phase II
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clinical Trial Phase III
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Post Marketing Surveillance or Phase IV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Pharmacovigilance Market, By Type of Method, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Spontaneous Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Intensified ADR Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Targeted Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cohort Event Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- EHR Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Pharmacovigilance Market, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- In-House
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Contract Outsourcing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Pharmacovigilance Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Accenture
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cognizant Technology Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Laboratory Corporation of America Holdings (LabCorp)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IBM Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QuintilesIMS (IQVIA)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ICON plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Capgemini
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ITClinical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- TAKE Solutions Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BioClinica
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PAREXEL International Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Wipro Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- FMD K&L
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Linical Accelovance
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- United BioSource Corporation (UBC)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PRA Health Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ArisGlobal
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ennov Solutions Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Accenture
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
